Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
White Star Capital is a global multi-stage venture capital and private equity firm that manages over $750 million across multiple funds. It primarily invests in early to growth-stage technology companies across sectors including commerce, SaaS, fintech, blockchain/Web3/digital assets. Notable investments include Dollar Shave Club, Meero, and Rymedi (blockchain medical records). It is not a drug developer or clinical-stage company and does not have a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on White Star Capital.